Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium

Andrea Gerhardt, Rüdiger E. Scharf, Ian A. Greer, Rainer B. Zotz

Blood (2016) 128 (19): 2343–2349.

https://doi.org/10.1182/blood-2016-03-703728

Published: 2016

Journal Articles

Risk Stratification of Recurrent Venous Thromboembolism.

Rainer B. Zotz, Andrea Gerhardt

Blood (2009) 114 (22): 2981.

https://doi.org/10.1182/blood.V114.22.2981.2981

Published: 2009

Journal Articles

A Concept for Long-Term Anticoagulation Based On the Individual Risk of Lethal Pulmonary Embolism (PE) and Lethal Bleeding Using Oral Anticoagulants.

Rainer B. Zotz, Christoph Sucker, Andrea Gerhardt

Blood (2009) 114 (22): 4174.

https://doi.org/10.1182/blood.V114.22.4174.4174

Published: 2009

Journal Articles

Longterm Prophylactic Treatment with Recombinant Factor VIIa (NovoSeven) in Severe Congenital Factor VII Deficient Patients

Andrea Gerhardt, Rudiger E. Scharf, MD, PhD, Rainer B. Zotz

Blood (2008) 112 (11): 4503.

https://doi.org/10.1182/blood.V112.11.4503.4503

Published: 2008

Journal Articles

Increased Plasminogen Activity Is An Independent Predictor of Bleeding in Hemophiliacs

Andrea Gerhardt, Melanie Pesch, Rudiger E. Scharf, MD, PhD, Rainer B. Zotz

Blood (2008) 112 (11): 4516.

https://doi.org/10.1182/blood.V112.11.4516.4516

Published: 2008

Journal Articles

Successful Use of Recombinant Factor VIIa (rVIIa, NovoSeven) in Two Patients with Bernard Soulier Syndrome and Dental Extraction

Rainer B. Zotz, Andrea Gerhardt, Rudiger E. Scharf, MD, PhD

Blood (2008) 112 (11): 4562.

https://doi.org/10.1182/blood.V112.11.4562.4562

Published: 2008

Journal Articles

Interaction Between Oral Contraceptive Use and Coagulation Factor Levels in Deep Vein Thrombosis

Rainer B. Zotz, Simone Kloeckner, Rudiger E. Scharf, MD, PhD, Andrea Gerhardt

Blood (2008) 112 (11): 4530.

https://doi.org/10.1182/blood.V112.11.4530.4530

Published: 2008

Journal Articles

Risk Determinants of Arterial Thrombosis Increase the Risk of Intrauterine Growth Restriction (IGR)

Andrea Gerhardt, Rudiger E. Scharf, MD, PhD, Rainer B. Zotz

Blood (2008) 112 (11): 5342.

https://doi.org/10.1182/blood.V112.11.5342.5342

Published: 2008

Journal Articles

Risk Determinants of Nonarteritic Ischemic Optic Neuropathy (NAION)

Rainer B. Zotz, Clara Finger, Andrea Gerhardt, Rudiger E. Scharf, MD, PhD

Blood (2008) 112 (11): 5349.

https://doi.org/10.1182/blood.V112.11.5349.5349

Published: 2008

Journal Articles

Successful Use of Recombinant Factor IX Concentrate (Nonacog-alfa, Benefix®) in Two Patients with Severe Hemophilia B and Total Knee Replacement (TKR).

Andrea Gerhardt, MD, Kristina Stahlschmidt, MD, Ansgar Ilg, MD, Rudiger E. Scharf, MD, Rainer B. Zotz, MD

Blood (2007) 110 (11): 3947.

https://doi.org/10.1182/blood.V110.11.3947.3947

Published: 2007

Journal Articles

The Risk of Intrauterine Growth Restriction (IGR) Is Increased by Risk Determinants of Arterial Thrombosis.

Andrea Gerhardt, MD, Nadja Howe, BS, Jan S. Krussel, MD, Hans G. Bender, MD, Rudiger E. Scharf, MD, Rainer B. Zotz, MD

Blood (2007) 110 (11): 2145.

https://doi.org/10.1182/blood.V110.11.2145.2145

Published: 2007

Journal Articles

Risk of Pregnancy-Associated Venous Thromboembolism in Women with a History of Prior Thrombosis.

Andrea Gerhardt, MD, Rudiger E. Scharf, MD, Rainer B. Zotz, MD

Blood (2006) 108 (11): 1493.

https://doi.org/10.1182/blood.V108.11.1493.1493

Published: 2006

Journal Articles

Women with the Prothrombophilic HPA-1b Genotype of Platelet Integrin αIIbβ3 Are at Increased Risk of Intrauterine Growth Restriction.

Andrea Gerhardt, MD, Nadja Howe, BS, Jan S. Kruessel, MD, Hans G. Bender, MD, Rudiger E. Scharf, MD, Rainer B. Zotz, MD

Blood (2006) 108 (11): 1487.

https://doi.org/10.1182/blood.V108.11.1487.1487

Published: 2006

Journal Articles

The Use of Recombinant Factor VIIa (NovoSeven®) in a Patient with Bernard Soulier Syndrome and Dental Extraction.

Andrea Gerhardt, MD, Rudiger E. Scharf, MD, Rainer B. Zotz, MD

Blood (2006) 108 (11): 3961.

https://doi.org/10.1182/blood.V108.11.3961.3961

Published: 2006

Journal Articles

Regular Prophylactic Treatment with Factor IX P® in a Patient with Severe Factor X Deficiency.

Andrea Gerhardt, MD, Fatima Araba, MD, Rainer B. Zotz, MD, Rudiger E. Scharf, MD

Blood (2006) 108 (11): 4050.

https://doi.org/10.1182/blood.V108.11.4050.4050

Published: 2006

Journal Articles

The IVS1-401 T-Allele of the Estrogen Receptor (ER)-α Is an Independent Predictor of Late Fetal Loss.

Andrea Gerhardt, MD, Rudiger E. Scharf, MD, Barbara Mikat-Drozdzynski, MD, Jan S. Kruessel, MD, Hans G. Bender, MD, Rainer B. Zotz, MD

Blood (2005) 106 (11): 4023.

https://doi.org/10.1182/blood.V106.11.4023.4023

Published: 2005

Journal Articles

Acquired Hemophilia: Single Center Experience with a Standardized Approach.

Christoph Sucker, Rainer B. Zotz, Rudiger E. Scharf, Andrea Gerhardt

Blood (2005) 106 (11): 4059.

https://doi.org/10.1182/blood.V106.11.4059.4059

Published: 2005

Journal Articles

A Hemophilia Patient with C1 Domain Arg2150His Mutation Developed a High Titer Inhibitor Not Inhibiting Autologous Factor VIII after Switching to Third Generation Recombinant Product.

Andrea Gerhardt, MD, Dirk Grotemeyer, MD, Wilhelm Sandmann, MD, Rudiger E. Scharf, MD, Rainer B. Zotz, MD

Blood (2005) 106 (11): 4060.

https://doi.org/10.1182/blood.V106.11.4060.4060

Published: 2005

Journal Articles

Interdisciplinary Management for Total Knee Replacement in Patients with Hemophilia and Severe Arthropathy.

Andrea Gerhardt, MD, Kristina Stahlschmidt, MD, Andreas Werner, MD, Ruediger Krauspe, MD, Ruediger E. Scharf, MD

Blood (2005) 106 (11): 4063.

https://doi.org/10.1182/blood.V106.11.4063.4063

Published: 2005

Journal Articles

New Approach for Evaluation of Quantitative Risk Factors of Venous Thromboembolism Using Individualized Reference Values.

Rainer B. Zotz, MD, Andrea Gerhardt, MD, Rudiger E. Scharf, MD

Blood (2005) 106 (11): 4022.

https://doi.org/10.1182/blood.V106.11.4022.4022

Published: 2005

NARROW

Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium

Risk Stratification of Recurrent Venous Thromboembolism.

A Concept for Long-Term Anticoagulation Based On the Individual Risk of Lethal Pulmonary Embolism (PE) and Lethal Bleeding Using Oral Anticoagulants.

Longterm Prophylactic Treatment with Recombinant Factor VIIa (NovoSeven) in Severe Congenital Factor VII Deficient Patients

Increased Plasminogen Activity Is An Independent Predictor of Bleeding in Hemophiliacs

Successful Use of Recombinant Factor VIIa (rVIIa, NovoSeven) in Two Patients with Bernard Soulier Syndrome and Dental Extraction

Interaction Between Oral Contraceptive Use and Coagulation Factor Levels in Deep Vein Thrombosis

Risk Determinants of Arterial Thrombosis Increase the Risk of Intrauterine Growth Restriction (IGR)

Risk Determinants of Nonarteritic Ischemic Optic Neuropathy (NAION)

Successful Use of Recombinant Factor IX Concentrate (Nonacog-alfa, Benefix®) in Two Patients with Severe Hemophilia B and Total Knee Replacement (TKR).

The Risk of Intrauterine Growth Restriction (IGR) Is Increased by Risk Determinants of Arterial Thrombosis.

Risk of Pregnancy-Associated Venous Thromboembolism in Women with a History of Prior Thrombosis.

Women with the Prothrombophilic HPA-1b Genotype of Platelet Integrin αIIbβ3 Are at Increased Risk of Intrauterine Growth Restriction.

The Use of Recombinant Factor VIIa (NovoSeven®) in a Patient with Bernard Soulier Syndrome and Dental Extraction.

Regular Prophylactic Treatment with Factor IX P® in a Patient with Severe Factor X Deficiency.

The IVS1-401 T-Allele of the Estrogen Receptor (ER)-α Is an Independent Predictor of Late Fetal Loss.

Acquired Hemophilia: Single Center Experience with a Standardized Approach.

A Hemophilia Patient with C1 Domain Arg2150His Mutation Developed a High Titer Inhibitor Not Inhibiting Autologous Factor VIII after Switching to Third Generation Recombinant Product.

Interdisciplinary Management for Total Knee Replacement in Patients with Hemophilia and Severe Arthropathy.

New Approach for Evaluation of Quantitative Risk Factors of Venous Thromboembolism Using Individualized Reference Values.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only